On 24 March 2017, the German authorities reported the contamination of a ‘do-it-yourself’ bacterial gene engineering CRISPR kit produced in the US. This publication assesses the risk related to the use of ‘do-it-yourself’ CRISPR-associated gene engineering kit contaminated with pathogenic bacteria.
Since March 2016, four EU Member States have reported a total of 40 cases of a new Salmonella serotype. This risk assessment discusses the suspected vehicle of infection and assesses the threat to public health in the EU/EEA.
This risk assessment is triggered by the increase in the number of yellow fever cases among EU travellers with exposure in South America since August 2016 and assesses the risk of contracting yellow fever for travellers to South America.
An outbreak of S. Enteritidis phage type 8 is ongoing in the EU/EEA. Isolates are part of two distinct but related genetic clusters. ECDC and EFSA are liaising with relevant authorities to facilitate the coordination of investigation response measures.
This rapid risk assessment is an update of a previous assessment on the ongoing transmission of hepatitis A virus infection mainly affecting men who have sex with men in EU/EEA countries.
This rapid risk assessment assesses the recurrent multi-country outbreak of Salmonella Enteritidis due to a persistent source of infection, with current or recent exposure in at least four EU/EEA Member States.
This updated rapid risk assessment gives an overview of an increase in the number of Salmonella Stourbridge cases in Germany during the second half of 2016, with other EU Member States also reporting cases.
This document assesses the risk to human health posed by a multi-country incident of botulism neurotoxin type E, possibly associated with consumption of a commercially-available dried and salted fish product.
This rapid risk assessment looks at the ongoing transmission of hepatitis A virus infection mainly affecting men who have sex with men in EU/EEA countries.